Cell & Gene Therapy Commercial Insight : April 2020

Cell & Gene Therapy Insights 2020; 6(5), 761–774

DOI: 10.18609/cgti.2020.089

Published: 3 July 2020
Commercial Insights
Mark Curtis, Richard Philipson

Providing a critical overview of the sector’s commercial development: M&As, licensing agreements & collaborations, financial results, IPOs and clinical/regulatory updates, with commentary from our Expert Contributors.